# RenaBio Therapeutics, Inc. — Form D

RenaBio Therapeutics, Inc. of NATICK, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-26. The offering totals $4.2M, of which $250K was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2025-02-26
- Form: D
- Accession: 0002018021-25-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $4.2M
- Amount sold: $250K
- Remaining: $3.9M
- Minimum investment: $5K
- Investors: 1
- Date of first sale: 2025-02-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-539252

## Issuer

- Name: RenaBio Therapeutics, Inc.
- CIK: 0002018021
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 22 STRATHMORE RD, #353, NATICK, MA, 01760
- Phone: (617) 721-0785

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Hans Bitter | Director | Natick, MA |
| Jafari Mousa | Director | Natick, MA |
| Shengjun Ren | Director | Natick, MA |
| Zhenghua Wang | Director | Natick, MA |
| Yu (Zoe) Zhang | Director | Natick, MA |
| Shengjun Ren | Executive Officer | Natick, MA |
| Ren Shengjun | Director | NATICK, MA |
| Ren Shengjun | Executive Officer | NATICK, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-04-03](https://search.stillhousedata.com/formd/0001080368-24-000012) | D | $4.0M | $1.0M |

## More

- [CIK 2018021 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2018021&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002018021-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.